NEO - ネオス・ファ―マシュ―ティカルズ (NeoGenomics Inc.) ネオス・ファ―マシュ―ティカルズ

 NEOのチャート


 NEOの企業情報

symbol NEO
会社名 Neos Therapeutics Inc (ネオス・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Precision Instruments  
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 事業概要 ネオゲノミクス(NeoGenomics Inc.)はがんに焦点を当てた遺伝子検査ラボのネットワークのオペレーターである。同社は実験室試験事業を運営する。実験室試験事業は病院、病理学者、腫瘍専門医、他の臨床医及び研究者に検査サービスを提供する。同社はフロリダ州マイアーズとタンパ、カリフォルニア州のアリソビエホ、フレズノ、アーバイン、ウエストサクラメント、並びにテキサス州のヒューストンとテネシー州のナッシュビルで実験室を有する。その実験室は細胞遺伝学、蛍光in-situハイブリダイゼーション(FISH)、フローサイトメトリー、免疫組織化学(IHC)、分子検査および病理学相談を含む検査サービスを提供する。製薬サービスと臨床試験グループは、製薬顧客の腫瘍学プログラムを、発見から商品化までサポートするために、テストサービスを提供する。同社は分子スクリーニングのための最適なプラットフォームを推薦し、意味のあるデータを収集するために情報科学を用いてその発見ツールを支援することによって、顧客がバイオマーカー仮説を立てるのに役立つ。   ネオス・ファ―マシュ―ティカルズは米国の医薬品会社。主に薬剤送達技術を利用し、既に商品化されている製薬の改良、開発に従事する。薬剤候補に、注意欠陥多動障害(ADHD)治療薬で、患者の負担が軽い徐放性タイプの経口薬を開発する。また、ADHD治療薬のメチルフェニデ―トとアンフェタミンの両方を取り入れた製薬も開発する。本社はキサス州。   NeoGenomics, Inc. is a clinical laboratory company, which specializes in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
本社所在地 2940 N. Hwy. 360 Grand Prairie TX 75050 USA
代表者氏名 Douglas M. VanOort Douglas M. VanOort
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 941-923-1949
設立年月日 34639
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 138人
url www.neostx.com
nasdaq_url https://www.nasdaq.com/symbol/neo
adr_tso
EBITDA EBITDA(百万ドル) 26.99500
終値(lastsale) 14.34
時価総額(marketcap) 1170709082.04
時価総額 時価総額(百万ドル) 1268.162
売上高 売上高(百万ドル) 262.01400
企業価値(EV) 企業価値(EV)(百万ドル) 1397.261
当期純利益 当期純利益(百万ドル) -4.77900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NeoGenomics Inc. revenues increased 10% to $131.2M. Net income applicable to common stockholders totaled $3.7M vs. loss of $5.9M. Revenues reflect Clinical testing segment increase of 7% to $116.5M Pharma Services segment increase of 30% to $14.7M. Net Income reflects Stock-based Compensation in R&D decrease of 18% to $269K (expense).

 NEOのテクニカル分析


 NEOのニュース

   „Der Anbräuner“ : So antwortet Neo Rauch auf die Kritik eines Kunsthistorikers  2020/11/24 09:00:00 Mitteldeutsche Zeitung
   Karate Combat: na primeira ‘batalha brasileira’ da história da organização, Bruno Assis supera Teeik Silva  2020/11/23 12:45:43 Globo Jornal Extra
Destaque com três dos quatro lutadores em ação, o Brasil foi o grande protagonista da nona edição da temporada 2020 do Karate Combat. O evento aconteceu no último domingo (22) no cenário "Neo Tokyo", uma das temáticas futuristas geradas por… Leia mais
   NeoGenomics (NASDAQ:NEO) PT Raised to $50.00  2020/11/20 13:32:42 Transcript Daily
NeoGenomics (NASDAQ:NEO) had its price objective increased by stock analysts at SVB Leerink from $47.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical research company’s stock. SVB Leerink’s target price points to a potential upside of 17.01% from […]
   NeoGenomics, Inc. (NASDAQ:NEO) Receives $40.68 Average PT from Analysts  2020/11/19 16:38:43 Transcript Daily
Shares of NeoGenomics, Inc. (NASDAQ:NEO) have earned an average rating of “Buy” from the fourteen analysts that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year […]
   Investment Analysts’ Weekly Ratings Changes for NeoGenomics (NEO)  2020/11/16 19:32:44 Transcript Daily
A number of research firms have changed their ratings and price targets for NeoGenomics (NASDAQ: NEO): 11/2/2020 – NeoGenomics was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating. 10/28/2020 – NeoGenomics had its price target raised by analysts at Raymond James from $40.00 to $48.00. They now have an “outperform” […]
   NEO Retains Steady Support from Imminent Moving Averages  2020/06/10 13:51:20 CryptoNewsZ
NEO has been trading fairly well amongst many altcoins of the market and had breached 3-month long resistance at $13.16.
   Keanu Reeves und Carrie-Anne Moss: Deshalb arbeiten sie an "Matrix 4"  2020/06/09 10:55:00 Stern
Carrie-Anne Moss und Keanu Reeves spielen in "Matrix 4" erneut Trinity und Neo. Überzeugt hat sie scheinbar das Drehbuch von Lana Wachowski.
   ESPAÑOL • Cannabis en Argentina, Blockchain Uruguayo, Elon Musk, Warren Buffett, Jeff Bezos, Isiah Thomas, y Canopy Growth  2020/06/05 21:19:01 Benzinga Feeds
Las últimas noticias sobre cannabis, cáñamo, CBD, psicodélicos, y otras temáticas verdes, ahora en Benzinga en Español, vía El Planteo . · Empresa Uruguaya Lanza Blockchain Para Cannabis Medicinal Por Javier Hasse. Uruguay Can, una compañía de cannabis que opera en Uruguay, lanzó esta semana una nueva plataforma basada en æternity, un blockchain descentralizado y escalable. La nueva plataforma permite una trazabilidad completa en el cultivo de cannabis medicinal, en lo que la compañía llama de “germinación a empaque”. Esta solución tecnológica busca elevar los estándares de seguridad, generando garantías con respecto a la calidad del producto final, tanto para el mercado local como para las exportaciones. · Continuar leyendo… · Cannabis en Argentina: Legalizar la Marihuana Podría Salvar la Economía Por Juan Ruocco. En la película Matrix, Morfeo le da una pastilla roja a Neo, el protagonista, que le permite ver la realidad y sacarlo de la simulación en la que está sumergido, pero que él cree que es el mundo real.
   Neo Rauch: "Gesäuberter Terminkalender war Erleichterung"  2020/06/05 12:41:22 T-Online
Der Künstler Neo Rauch und seine Frau Rosa Loy haben den coronabedingten Einschränkungen durchaus etwa Positives abgewonnen. "Wir haben beide den von Terminen gesäuberten Kalender als Erleichterung empfunden", sagte Rauch anlässlich der Präsentation der neuen Jahresausstellung der Grafikstiftung Neo
   Ausstellung zeigt frühe Papierarbeiten Neo Rauchs  2020/06/05 12:21:21 T-Online
Die Grafikstiftung Neo Rauch in Aschersleben widmet ihre neunte Jahresausstellung den frühen Papierarbeiten des zeitgenössischen Künstlers aus Leipzig. Die Schau "Das Fortwährende" ist von Samstag an bis 2. Mai 2021 zu sehen, teilte die Stiftung am Freitag in Aschersleben mit. Präsentiert werden run
   NEO price analysis: Buyers looking at $10.00 resistance area  2020/04/30 16:06:00 Capital.com
NEO price analysis indicates that more gains towards the $9.60 to $10.00 level appear likely. The recent advance has created negative MACD price divergence. Read More…
   NeoGenomics (NEO) Reports Q1 Loss, Misses Revenue Estimates  2020/04/28 13:35:02 Zacks Investment Research
NeoGenomics (NEO) delivered earnings and revenue surprises of -200.00% and -0.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Cuarentena gym: inventan un gadget para que todas las bicis puedan ser fijas  2020/04/24 10:46:15 Clarin
Tacx NEO 2T Smart Trainer es un sistema de entrenamiento inteligente que permite transformar cualquier bicicleta en estática.
   Ethereum Developers Roll Up Their Sleeves in Hunt for Scalability Cure  2020/04/23 16:40:00 Cointelegraph
Why hasn’t the Ethereum blockchain found the perfect solution for its scalability problem since 2014, and does one really exist? The Ethereum team has been trying to solve the blockchain scalability problem since 2014. During that time, solutions such as Raiden, Plasma, zk-SNARKs, sharding and rollups appeared in the developers’ tool kit. However, the implementation of some of them was constantly delayed, while others proved to be of limited efficacy. This was the issue until Ethereum’s Istanbul hard fork was implemented in December 2019, which gave hope that the network can finally become suitable for corporate use. Cointelegraph attempted to figure out whether the situation with the second-largest cryptocurrency’s scalability has changed and why not all the solutions have cut the mustard. Why should Ethereum scale? The Ethereum ( ETH ) blockchain has become a software for thousands of projects over the past couple of years. Its easy-to-use smart contract model allows for the creation of almost any application and a release of the project’s own cryptocurrency.
   RattanIndia Finance remporte le prix Celent Model Bank Award 2020 pour les prêts de détail basés sur Nucleus FinnOne Neo  2020/04/23 03:00:00 PR Newswire
- Délai de mise sur le marché réduit de 50 %, permettant à RattanIndia de devenir la première entreprise à offrir des prêts pour des vélos électriques en Inde - Coût d'acquisition réduit de 90 % NEW DELHI, 23 avril 2020 /PRNewswire/ -- Celent, la plus grande société de recherche, de…

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 ネオス・ファ―マシュ―ティカルズ NEO NeoGenomics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)